Helius Medical Technologies, Inc. (HSDT)
- Previous Close
4.5000 - Open
4.4300 - Bid --
- Ask --
- Day's Range
4.4200 - 4.6892 - 52 Week Range
4.2900 - 14.4500 - Volume
5,124 - Avg. Volume
405,746 - Market Cap (intraday)
3.993M - Beta (5Y Monthly) 1.55
- PE Ratio (TTM)
-- - EPS (TTM)
-14.5600 - Earnings Date May 9, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
15.47
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
heliusmedical.comRecent News: HSDT
Performance Overview: HSDT
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HSDT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HSDT
Valuation Measures
Market Cap
3.99M
Enterprise Value
-1.13M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.25
Price/Book (mrq)
1.70
Enterprise Value/Revenue
-1.76
Enterprise Value/EBITDA
0.09
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-61.40%
Return on Equity (ttm)
-168.55%
Revenue (ttm)
644k
Net Income Avi to Common (ttm)
-8.85M
Diluted EPS (ttm)
-14.5600
Balance Sheet and Cash Flow
Total Cash (mrq)
5.18M
Total Debt/Equity (mrq)
2.43%
Levered Free Cash Flow (ttm)
-6.11M